author={Elena Barengolts},
  journal={Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists},
  volume={22 10},
  • E. Barengolts
  • Published 13 July 2016
  • Medicine
  • Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
OBJECTIVE To review the data from randomized controlled trials (RCTs) for the roles of microbiota, pre-, pro- and synbiotics in metabolic conditions (obesity, prediabetes, and diabetes mellitus type 2 [DM2]). METHODS Primary literature was reviewed on the topics including RCTs of pre-, pro- and synbiotics use for metabolic disease. RESULTS Gut bacteria (microbiota) benefit digestion and have multiple other functions. Microbiota could increase harvesting of energy from the food and cause… 

Tables from this paper

Probiotics, prebiotics and synbiotics for weight loss and metabolic syndrome in the microbiome era.

Diet supplementation with synbiotics prepared using selected strains showed to exert weight-reduction and anti-inflammatory activity in large independent studies and may increase weight management effects due to synergistic effect on short chain fatty acid production and microbiota 're-configuration'.

Synbiotic Supplementation Improves Obesity Index and Metabolic Biomarkers in Thai Obese Adults: A Randomized Clinical Trial

The biomarkers of obesity, such as cholesterol, gut permeability, oxidative stress, bacterial toxins, cytokines, and short-chain fatty acids, were analyzed in Thai obese individuals after being supplemented with a synbiotic preparation containing Lactobacillus paracasei, Bifidobacterium longum, B ifidobacteria breve, inulin, and fructooligosaccharide.

Prebiotic and probiotic treatment of nonalcoholic fatty liver disease: a systematic review and meta-analysis

A meta-analysis supports the potential use of microbial therapies in the treatment of NAFLD and sheds light on their potential mode of action.

Efficacy of Probiotics and Synbiotics in Patients with Nonalcoholic Fatty Liver Disease: A Meta-Analysis

Background and AimExtensive epidemiological evidence suggests that nonalcoholic fatty liver disease (NAFLD) is the primary chronic liver disease worldwide. However, some studies have showed

Human microbiome and metabolic health: An overview of systematic reviews

Meta‐evidence was highest for probiotics and lowest for fecal transplant, and discriminating bacteria overlapped between metabolic disorders, those with high abundance being often involved in inflammation, whereas those with low abundance being used as probiotics.

The Effect of Probiotic Yogurt on Glycemic Control in Type 2 Diabetes or Obesity: A Meta-Analysis of Nine Randomized Controlled Trials

Larger trials are needed to verify the benefits of probiotic and/or conventional yogurt or other probiotic fermented milk on glycemic markers in patients with diabetes and obesity.

Microbial Population Changes and Their Relationship with Human Health and Disease

Research in this field is currently in its infancy, which may be due to the large number of factors that can elicit such alterations, the variety of related pathologies, and the heterogeneity of the population involved.

Possible Benefits of Faecalibacterium prausnitzii for Obesity-Associated Gut Disorders

This review examines the interplay between gut inflammation, insulin resistance, and the gut microbiota, and discusses how some probiotic species can be used to modulate gut homeostasis and focuses primarily on Faecalibacterium prausnitzii, a highly abundant butyrate-producing bacterium.

An Insight into the Changing Scenario of Gut Microbiome during Type 2 Diabetes

Interventions that can restore equilibrium in the GM have beneficial effects and can improve glycemic control, and the exact mechanisms behind the dynamics of gut microbes and their impact on host metabolism are yet to be deciphered.



Vitamin D and prebiotics may benefit the intestinal microbacteria and improve glucose homeostasis in prediabetes and type 2 diabetes.

  • E. Barengolts
  • Biology, Medicine
    Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
  • 2013
Emerging evidence suggests an important role of microbiota in glucose homeostasis and VD supplementation and prebiotics may be useful in managing PreDM and T2DM.

Dietary modulation of the gut microbiota – a randomised controlled trial in obese postmenopausal women

Investigating the effect of interventions with Lactobacillus paracasei F19 or flaxseed mucilage on the gut microbiota and metabolic risk markers in obesity found improvement in insulin sensitivity was not mediated by the observed changes in relative abundance of bacterial species.

A mixture of trans-galactooligosaccharides reduces markers of metabolic syndrome and modulates the fecal microbiota and immune function of overweight adults.

Administration of B-GOS to overweight adults resulted in positive effects on the composition of the gut microbiota, the immune response, and insulin, TC, and TG concentrations, which may be a useful candidate for the enhancement of gastrointestinal health, immune function, and the reduction of metabolic syndrome risk factors in overweight adults.

Effect of Multispecies Probiotic Supplements on Metabolic Profiles, hs-CRP, and Oxidative Stress in Patients with Type 2 Diabetes

In conclusion, multispecies probiotic supplementation, compared with placebo, for 8 weeks in diabetic patients prevented a rise in FPG and resulted in a decrease in serum hs-CRP and an increase in plasma total GSH.

The effects of probiotic bacteria on glycaemic control in overweight men and women: a randomised controlled trial

Data from this study does not support the hypothesis that L. acidophilus La5 and B. animalis subsp lactis Bb12, either in isolated form or as part of a whole food, benefit short-term glycaemic control, and there is weak data for an adverse effect of these strains on glucose homoeostasis.

Insight into the prebiotic concept: lessons from an exploratory, double blind intervention study with inulin-type fructans in obese women

ITF prebiotics selectively changed the gut microbiota composition in obese women, leading to modest changes in host metabolism, as suggested by the correlation between some bacterial species and metabolic endotoxaemia or metabolomic signatures.

Potential probiotic Bifidobacterium animalis ssp. lactis 420 prevents weight gain and glucose intolerance in diet-induced obese mice.

Reduced intestinal mucosal adherence and plasma lipopolysaccharide suggest a mechanism related to reduced translocation of gut microbes that reduces fat mass and glucose intolerance in both obese and diabetic mice.

Effects of synbiotic supplementation on insulin resistance in subjects with the metabolic syndrome: a randomised, double-blind, placebo-controlled pilot study

The present results indicate that synbiotic supplementation increases the efficacy of diet therapy in the management of the metabolic syndrome and insulin resistance.